Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Shering C"'
Autor:
Lloyd C; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Freskgård PO; BioArctic AB, Stockholm, Sweden., Newton P; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Lowne D; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Nickson A; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Bogstedt A; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Eketjäll S; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Höglund K; Center for Medical Genomics, Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Göteborg, Sweden., Gustavsson S; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Welsh F; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Chessell T; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., McFarlane M; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Bhat RV; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Turner R; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Perkinton MS; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Santisteban Valencia Z; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lindqvist E; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Pomfret M; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dudley AD; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Vaughan TJ; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Groves MT; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Natanegara F; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA., Feng Y; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA., Sims JR; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA., Proctor NK; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA., Dage JL; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Shering C; BioPharmaceuticals R&D, AstraZeneca, Cambridge, Massachusetts, USA., Tan K; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ostenfeld T; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Billinton A; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Chessell IP; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Publikováno v:
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Boada M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Rodrigo A; GMV SECURE E SOLUTIONS, Valencia, Spain., Jessen F; Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Wimblad B; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.; Theme Aging, Karolinska Univ Hospital, Stockholm, Sweden., Kramberger MG; Department of Neurology, University Medical Center Ljubljana and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Visser PJ; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands., Simó R; Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain., Rodríguez-Gomez O; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain., Ciudin A; Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain., Georges J; Alzheimer Europe, Luxembourg., Dumas A; ASDM Consulting, Brussels, Belgium., Maguire P; European Institute of Women's Health, Dublin, Ireland., Krivec D; Zdruzenje Spomincica, Ljubljana, Slovenia., Wimo A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Valero S; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Alegret M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Jamilis L; GMV SECURE E SOLUTIONS, Valencia, Spain., Zwan M; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Sannemann L; Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Arrufat J; EAP Sarrià-Vallvidrera-Les Planes, Barcelona, Spain., Stomrud E; Clinical Memory Research Unit, Lund University, Malmö, Sweden.; Emmaboda Health Centre, Region Kalmar County, Emmaboda, Sweden., Johansson G; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Shering C; AstraZeneca, Waltham, Massachusetts, USA., Glaysher B; Modus Research and Innovation Limited, Dundee, Scotland., Stewart N; Modus Research and Innovation Limited, Dundee, Scotland., Belger M; Eli Lilly and Company (Lilly UK), Surrey, UK., Iradier F; Eli Lilly and Company, Spain., Campo L; Eli Lilly and Company, Firenze, Italy.
Publikováno v:
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2022 Jun; Vol. 18 (6), pp. 1119-1127. Date of Electronic Publication: 2021 Jul 26.
Autor:
Zimmer JA; Eli Lilly and Company Indianapolis Indiana USA., Shcherbinin S; Eli Lilly and Company Indianapolis Indiana USA., Devous MD Sr; Eli Lilly and Company Indianapolis Indiana USA., Bragg SM; Eli Lilly and Company Indianapolis Indiana USA., Selzler KJ; Eli Lilly and Company Indianapolis Indiana USA., Wessels AM; Eli Lilly and Company Indianapolis Indiana USA., Shering C; AstraZeneca, Neuroscience Biopharmaceuticals R&D Boston Massachusetts USA., Mullen J; AstraZeneca, Neuroscience Biopharmaceuticals R&D Boston Massachusetts USA., Landry J; Eli Lilly and Company Indianapolis Indiana USA., Andersen SW; Eli Lilly and Company Indianapolis Indiana USA., Downing AM; Eli Lilly and Company Indianapolis Indiana USA., Fleisher AS; Eli Lilly and Company Indianapolis Indiana USA., Svaldi DO; Eli Lilly and Company Indianapolis Indiana USA., Sims JR; Eli Lilly and Company Indianapolis Indiana USA.
Publikováno v:
Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2021 Feb 14; Vol. 7 (1), pp. e12123. Date of Electronic Publication: 2021 Feb 14 (Print Publication: 2021).
Autor:
Wessels AM; Eli Lilly and Company, Indianapolis, Indiana, USA., Lines C; Merck & Co., Inc., Kenilworth, New Jersey, USA., Stern RA; Alzheimer's Disease Center, Boston University School of Medicine, Boston, Massachusetts, USA., Kost J; Merck & Co., Inc., Kenilworth, New Jersey, USA., Voss T; Merck & Co., Inc., Kenilworth, New Jersey, USA., Mozley LH; Merck & Co., Inc., Kenilworth, New Jersey, USA., Furtek C; Merck & Co., Inc., Kenilworth, New Jersey, USA., Mukai Y; Merck & Co., Inc., Kenilworth, New Jersey, USA., Aisen PS; University of Southern California, San Diego, California, USA., Cummings JL; Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV) and Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA., Tariot PN; Banner Alzheimer's Institute, Phoenix, Arizona, USA., Vellas B; Gerontopole, INSERM U1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse, France., Dupre N; Merck & Co., Inc., Kenilworth, New Jersey, USA., Randolph C; MedAvante-ProPhase, Hamilton, NJ and Department of Neurology, Loyola University Medical Center, Maywood, Illinois, USA., Michelson D; Merck & Co., Inc., Kenilworth, New Jersey, USA., Andersen SW; Eli Lilly and Company, Indianapolis, Indiana, USA., Shering C; AstraZeneca, Boston, Massachusetts, USA., Sims JR; Eli Lilly and Company, Indianapolis, Indiana, USA., Egan MF; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Publikováno v:
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2020 Nov; Vol. 16 (11), pp. 1483-1492. Date of Electronic Publication: 2020 Oct 13.
Autor:
Wessels AM; Eli Lilly and Company, Indianapolis, Indiana., Tariot PN; Banner Alzheimer's Institute, University of Arizona College of Medicine, Phoenix., Zimmer JA; Eli Lilly and Company, Indianapolis, Indiana., Selzler KJ; Eli Lilly and Company, Indianapolis, Indiana., Bragg SM; Eli Lilly and Company, Indianapolis, Indiana., Andersen SW; Eli Lilly and Company, Indianapolis, Indiana., Landry J; Eli Lilly and Company, Indianapolis, Indiana., Krull JH; Eli Lilly and Company, Indianapolis, Indiana., Downing AM; Eli Lilly and Company, Indianapolis, Indiana., Willis BA; Eli Lilly and Company, Indianapolis, Indiana., Shcherbinin S; Eli Lilly and Company, Indianapolis, Indiana., Mullen J; AstraZeneca, Waltham, Massachusetts, and Gaithersburg, Maryland.; Now retired., Barker P; AstraZeneca, Waltham, Massachusetts, and Gaithersburg, Maryland., Schumi J; AstraZeneca, Waltham, Massachusetts, and Gaithersburg, Maryland., Shering C; AstraZeneca, Waltham, Massachusetts, and Gaithersburg, Maryland., Matthews BR; Eli Lilly and Company, Indianapolis, Indiana., Stern RA; Alzheimer's Disease Center, Boston University School of Medicine, Boston, Massachusetts., Vellas B; Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Unités Mixtes de Recherche Institut National de la Santé et de la Recherche Médicale 1027, Université Toulouse III-Paul Sabatier, Toulouse, France., Cohen S; Toronto Memory Program, Toronto, Ontario, Canada., MacSweeney E; Re:Cognition Health, London, United Kingdom., Boada M; Research Center and Memory Clinic, Fundació Alzheimer Centre Educacional, Institut Català de Neurociències Aplicades, Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Sims JR; Eli Lilly and Company, Indianapolis, Indiana.
Publikováno v:
JAMA neurology [JAMA Neurol] 2020 Feb 01; Vol. 77 (2), pp. 199-209.
Autor:
Rodríguez-Gómez O; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain. Electronic address: orodriguez@fundacioace.org., Rodrigo A; GMV SECURE E SOLUTIONS, Valencia, Spain., Iradier F; Eli Lilly and Company (Lilly España), Alcobendas, Spain., Santos-Santos MA; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain., Hundemer H; Eli Lilly and Company (Lilly Deutschland GmbH), Bad Homburg, Germany., Ciudin A; Vall d'Hebron Research Institute (VHIR) and CIBERDEM (ISCIII), Barcelona, Spain., Sannemann L; Department of Psychiatry, University of Cologne, Cologne, Germany., Zwan M; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Glaysher B; Modus Research and Innovation Limited, Dundee, Scotland., Wimo A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden., Bonn J; Center for Cognitive Impairments, Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia., Johansson G; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden., Rodriguez I; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain., Alegret M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Gove D; Alzheimer Europe, Luxembourg., Pinó S; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain., Trigueros P; GMV SECURE E SOLUTIONS, Valencia, Spain., Kivipelto M; Division of Clinical Geriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden; Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland., Mathews B; Eli Lilly and Company, Indianapolis, IN, USA., Ciudad A; Eli Lilly and Company (Lilly España), Alcobendas, Spain., Ferreira D; Division of Clinical Geriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden., Bintener C; Alzheimer Europe, Luxembourg., Gurruchaga M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain., Westman E; Division of Clinical Geriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden; Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK., Belger M; Eli Lilly and Company (Lilly UK), Surrey, UK., Valero S; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Maguire P; European Institute of Womenś Health, Dublin, Ireland., Krivec D; Združenje Spominčica, Ljubljana, Slovenia., Kramberger M; Center for Cognitive Impairments, Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia., Simó R; Vall d'Hebron Research Institute (VHIR) and CIBERDEM (ISCIII), Barcelona, Spain., Garro IP; GMV SECURE E SOLUTIONS, Valencia, Spain., Visser PJ; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands., Dumas A; ASDM Consulting, Brussels, Belgium., Georges J; Alzheimer Europe, Luxembourg., Jessen F; Department of Psychiatry, University of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Winblad B; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Karolinska Univ Hospital, Theme Aging, Stockholm, Sweden., Shering C; AstraZeneca, Waltham, MA, USA., Stewart N; Modus Research and Innovation Limited, Dundee, Scotland., Campo L; Eli Lilly and Company, Firenze, Italy., Boada M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain.
Publikováno v:
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2019 Jun; Vol. 15 (6), pp. 828-839. Date of Electronic Publication: 2019 May 07.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Puzzo, Daniela
Publikováno v:
Journal of Alzheimer's Disease; 2024, Vol. 100 Issue 3, p783-786, 4p
Publikováno v:
Journal of Alzheimer's Disease; 2024, Vol. 100 Issue 3, p911-921, 11p
Autor:
Duff, Kevin1,2 (AUTHOR) Duffk@ohsu.edu, Dixon, Ava M.2 (AUTHOR), Embree, Lindsay2 (AUTHOR), Hoffman, John M.3,4 (AUTHOR)
Publikováno v:
Journal of Clinical & Experimental Neuropsychology. Mar2023, Vol. 45 Issue 2, p105-117. 13p. 3 Charts, 1 Graph.